To deepen the reform of the drug review and approval system, encourage innovation, and further promote the research and quality improvement of drug clinical practice in China, NMPA, in conjunction with NHC, has organized the revision of the Good Clinical Practice (GCP), which has been released on April 26, 2020, and shall enter into effect as from July 1, 2020.